Ptc Therapeutics (PTCT) Finished Goods (2019 - 2026)

Ptc Therapeutics' Finished Goods history runs 8 years deep, the most recent figure standing at $21.2 million for Q1 2026.

• On a quarterly basis, Finished Goods rose 225.27% year-over-year to $21.2 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 225.27% increase from a year earlier, with the FY2025 full-year figure at $21.7 million, up 156.75% from the prior year.
• Finished Goods fell to $21.2 million in Q1 2026 per PTCT's latest filing, from $21.7 million in the prior quarter.
• Across five years, Finished Goods topped out at $21.7 million in Q4 2025 and bottomed at $5.7 million in Q1 2022.
• The 5-year median for Finished Goods is $7.5 million (2025), against an average of $9.4 million.
• Across the five-year window, Finished Goods sank 33.45% in 2024 and soared 225.27% in 2026, its largest moves.
• Year by year, Finished Goods stood at $6.7 million in 2022, then jumped by 74.79% to $11.6 million in 2023, then fell by 27.45% to $8.4 million in 2024, then surged by 156.75% to $21.7 million in 2025, then slipped by 2.33% to $21.2 million in 2026.
• Per Business Quant, the three latest PTCT Finished Goods figures stand at $21.2 million (Q1 2026), $21.7 million (Q4 2025), and $8.6 million (Q3 2025).